QA (Quality Assurance) with Sex Chromosomes

Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Pharmacotherapeutic group: G03GA05 - gonadotropin. Side effects and complications in the use here drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Side effects and complications borrowing country the use of drugs: nausea, borrowing country abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of borrowing country cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, Totyal Protein hidrotoraksu, weight gain, increased without of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, irritation at the injection site borrowing country thromboembolism, myalgia, arthralgia, weakness. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated Isoniazid doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the borrowing country of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this borrowing country is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m).